Symbols / KYNB Stock $7.08 +1.14% Kyntra Bio, Inc.

Healthcare • Biotechnology • United States • NMS
KYNB (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Kyntra Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing FG-3246, a potential antibody-drug conjugate targeting CD46, for the treatment of metastatic castration-resistant prostate cancer and other cancers. It is also developing Roxadustat, a small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. The company was formerly known as FibroGen, Inc. and change its name to Kyntra Bio, Inc. in January 2026. Kyntra Bio, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.

Stock Fundamentals
Scroll to Statements
Market Cap 28.65M Enterprise Value -5.81M Income -58.20M Sales 6.44M Book/sh -7.42 Cash/sh 21.99
Dividend Yield — Payout 0.00% Employees 34 IPO — P/E — Forward P/E -0.69
PEG — P/S 4.45 P/B -0.95 P/C — EV/EBITDA 0.13 EV/Sales -0.90
Quick Ratio 3.19 Current Ratio 3.39 Debt/Eq 437.10 LT Debt/Eq — EPS (ttm) -14.40 EPS next Y -10.25
EPS Growth — Revenue Growth -59.30% Earnings 2026-05-11 ROA -16.96% ROE — ROIC —
Gross Margin -273.80% Oper. Margin -10.59% Profit Margin 28.49% Shs Outstand 4.05M Shs Float 3.56M Short Float 2.87%
Short Ratio 3.24 Short Interest — 52W High 12.60 52W Low 4.85 Beta 0.90 Avg Volume 31.69K
Volume 1.27K Target Price $43.00 Recom None Prev Close $7.00 Price $7.08 Change 1.14%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$43.00
Mean price target
2. Current target
$7.08
Latest analyst target
3. DCF / Fair value
$22.73
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$7.08
Low
$43.00
High
$43.00
Mean
$43.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-09-24 reit HC Wainwright & Co. Buy → Buy $43
2025-08-07 main HC Wainwright & Co. Buy → Buy $43
News
RSS: Latest KYNB news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-11-17 WETTIG THANE Chief Executive Officer — 3,700 $9.10 $33,750
2025-06-30 SCHOENECK JAMES A Director — 23,567 $5.07 $119,485
2025-03-24 WETTIG THANE Chief Executive Officer — 145,000 $0.35 $50,663
2025-03-21 SCHOENECK JAMES A Director — 300,000 $0.34 $105,040
2025-03-06 CHUNG CHRISTINE Officer — 781 — —
2025-03-06 WETTIG THANE Chief Executive Officer — 781 — —
2024-06-12 ADIB DEYAA Officer — 22,123 $1.17 $25,884
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
6.44
-78.26%
29.62
-36.71%
46.80
-66.74%
140.73
Operating Revenue
6.44
-78.17%
29.50
-36.96%
46.80
-66.74%
140.73
Cost Of Revenue
0.56
-96.43%
15.56
+292.76%
3.96
-80.46%
20.28
Reconciled Cost Of Revenue
0.56
-96.43%
15.56
+292.76%
3.96
-80.46%
20.28
Gross Profit
5.88
-58.15%
14.06
-67.18%
42.84
-64.43%
120.45
Operating Expense
51.23
-64.68%
145.02
-58.91%
352.96
-16.26%
421.48
Research And Development
23.52
-75.42%
95.69
-64.09%
266.47
-10.22%
296.79
Selling General And Administration
27.71
-43.83%
49.33
-42.96%
86.48
-30.64%
124.69
Total Expenses
51.78
-67.75%
160.58
-55.01%
356.92
-19.21%
441.76
Operating Income
-45.34
+65.38%
-130.96
+57.77%
-310.12
-3.02%
-301.02
Total Operating Income As Reported
-45.90
+69.49%
-150.42
+53.39%
-322.72
-7.21%
-301.02
EBITDA
-48.79
+65.75%
-142.43
+53.33%
-305.20
-7.91%
-282.82
Normalized EBITDA
-41.65
+66.13%
-122.97
+57.97%
-292.59
-3.45%
-282.82
Reconciled Depreciation
0.75
-72.21%
2.69
-72.89%
9.93
-6.36%
10.60
EBIT
-49.53
+65.87%
-145.12
+53.95%
-315.13
-7.39%
-293.43
Total Unusual Items
-7.14
+63.32%
-19.45
-54.32%
-12.61
0.00
Total Unusual Items Excluding Goodwill
-7.14
+63.32%
-19.45
-54.32%
-12.61
0.00
Special Income Charges
-7.14
+63.32%
-19.45
-54.32%
-12.61
0.00
Other Special Charges
6.58
—
—
—
Restructuring And Mergern Acquisition
0.55
-97.16%
19.45
+54.32%
12.61
0.00
Net Income
183.45
+485.57%
-47.58
+83.26%
-284.23
+3.21%
-293.65
Pretax Income
-58.29
+61.99%
-153.37
+52.55%
-323.22
-9.62%
-294.87
Net Non Operating Interest Income Expense
-5.82
-97.09%
-2.95
-489.02%
-0.50
-108.14%
6.16
Interest Expense Non Operating
8.76
+6.21%
8.25
+1.88%
8.10
+462.15%
1.44
Net Interest Income
-5.82
-97.09%
-2.95
-489.02%
-0.50
-108.14%
6.16
Interest Expense
8.76
+6.21%
8.25
+1.88%
8.10
+462.15%
1.44
Interest Income Non Operating
2.94
-44.43%
5.30
-30.26%
7.59
-0.03%
7.60
Interest Income
2.94
-44.43%
5.30
-30.26%
7.59
-0.03%
7.60
Other Income Expense
-7.14
+63.32%
-19.45
-54.32%
-12.61
—
Tax Provision
-0.09
+66.54%
-0.27
-6.75%
-0.25
-170.39%
0.36
Tax Rate For Calcs
0.00
+14.03%
0.00
+75.40%
0.00
-99.52%
0.00
Tax Effect Of Unusual Items
-0.01
+58.17%
-0.03
-170.68%
-0.01
0.00
Net Income Including Noncontrolling Interests
183.45
+485.57%
-47.58
+83.26%
-284.23
+3.21%
-293.65
Net Income From Continuing Operation Net Minority Interest
-58.20
+61.98%
-153.10
+52.60%
-322.97
-9.98%
-293.65
Net Income From Continuing And Discontinued Operation
183.45
+485.57%
-47.58
+83.26%
-284.23
+3.21%
-293.65
Net Income Continuous Operations
-58.20
+61.98%
-153.10
+52.60%
-322.97
-9.98%
-293.65
Net Income Discontinuous Operations
241.66
+129.02%
105.52
+172.39%
38.74
—
Normalized Income
-51.08
+61.79%
-133.68
+56.93%
-310.38
-5.69%
-293.65
Net Income Common Stockholders
183.45
+485.57%
-47.58
+83.26%
-284.23
+3.21%
-293.65
Diluted EPS
45.37
+478.08%
-12.00
+83.56%
-73.00
+7.01%
-78.50
Basic EPS
45.37
+478.08%
-12.00
+83.56%
-73.00
+7.01%
-78.50
Basic Average Shares
4.04
+1.03%
4.00
+2.82%
3.89
+3.98%
3.74
Diluted Average Shares
4.04
+1.03%
4.00
+2.82%
3.89
+3.98%
3.74
Diluted NI Availto Com Stockholders
183.45
+485.57%
-47.58
+83.26%
-284.23
+3.21%
-293.65
Earnings From Equity Interest Net Of Tax
—
—
2.64
+67.71%
1.57
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
119.59
-44.25%
214.53
-49.35%
423.53
-30.58%
610.09
Current Assets
99.07
-49.58%
196.51
-40.73%
331.56
-32.72%
492.83
Cash Cash Equivalents And Short Term Investments
88.98
+76.26%
50.48
-75.19%
203.45
-51.79%
422.01
Cash And Cash Equivalents
47.87
-5.17%
50.48
-38.10%
81.55
-47.62%
155.70
Cash Equivalents
45.56
-6.01%
48.48
-3.61%
50.29
+152.97%
19.88
Cash Financial
2.31
+15.22%
2.00
-93.59%
31.26
-76.98%
135.82
Other Short Term Investments
41.11
0.00
-100.00%
121.90
-54.23%
266.31
Receivables
4.22
-85.45%
28.98
-13.80%
33.62
+106.28%
16.30
Accounts Receivable
0.22
-55.09%
0.48
-90.61%
5.12
-68.58%
16.30
Other Receivables
4.00
-85.96%
28.50
+0.00%
28.50
—
Inventory
3.74
+18.64%
3.15
-81.63%
17.17
-57.53%
40.44
Raw Materials
—
0.00
-100.00%
0.79
-36.58%
1.24
Work In Process
3.74
+18.64%
3.15
-80.75%
16.39
-54.49%
36.00
Finished Goods
—
—
5.58
+74.66%
3.19
Prepaid Assets
1.01
-46.66%
1.90
-60.80%
4.86
-50.10%
9.73
Assets Held For Sale Current
0.00
-100.00%
110.85
+68.52%
65.78
—
Other Current Assets
1.12
-1.58%
1.14
-82.96%
6.68
+53.53%
4.35
Total Non Current Assets
20.52
+13.90%
18.02
-80.41%
91.97
-21.57%
117.26
Net PPE
—
0.00
-100.00%
69.72
-30.62%
100.50
Gross PPE
—
0.00
-100.00%
211.10
-15.99%
251.28
Accumulated Depreciation
—
0.00
+100.00%
-141.38
+6.23%
-150.78
Properties
—
0.00
0.00
0.00
Machinery Furniture Equipment
—
0.00
-100.00%
12.23
-51.70%
25.33
Construction In Progress
—
—
0.06
-69.61%
0.20
Other Properties
—
—
113.95
-7.48%
123.17
Leases
—
0.00
-100.00%
84.92
-17.22%
102.58
Investments And Advances
20.16
0.00
-100.00%
5.29
-43.78%
9.41
Long Term Equity Investment
—
—
5.29
+4.52%
5.06
Other Investments
20.16
0.00
0.00
-100.00%
4.35
Other Non Current Assets
0.36
-98.00%
18.02
-19.01%
22.25
+202.50%
7.35
Total Liabilities Net Minority Interest
115.12
-71.09%
398.16
-32.02%
585.73
-4.23%
611.57
Current Liabilities
29.24
-78.06%
133.31
-38.76%
217.67
-20.43%
273.56
Payables And Accrued Expenses
20.77
-41.85%
35.72
-67.77%
110.85
-54.44%
243.28
Payables
3.75
-26.05%
5.06
-67.90%
15.78
-58.96%
38.45
Accounts Payable
3.75
-26.05%
5.06
-67.90%
15.78
-48.70%
30.76
Current Accrued Expenses
17.03
-44.46%
30.66
-67.75%
95.07
-53.59%
204.83
Total Tax Payable
—
—
6.62
-13.99%
7.69
Current Debt And Capital Lease Obligation
—
—
12.65
+22.88%
10.29
Current Capital Lease Obligation
—
0.00
-100.00%
12.65
+22.88%
10.29
Current Deferred Liabilities
5.31
-80.53%
27.29
+114.21%
12.74
+0.01%
12.74
Current Deferred Revenue
5.31
-80.53%
27.29
+114.21%
12.74
+0.01%
12.74
Other Current Liabilities
3.15
-95.51%
70.29
-13.68%
81.43
+1023.54%
7.25
Total Non Current Liabilities Net Minority Interest
85.88
-67.58%
264.85
-28.04%
368.06
+8.89%
338.00
Liabilities Heldfor Sale Non Current
0.00
-100.00%
0.36
-76.33%
1.50
-96.95%
49.33
Long Term Debt And Capital Lease Obligation
—
73.09
-46.64%
136.97
+72.08%
79.59
Long Term Debt
—
73.09
+1.61%
71.93
—
Long Term Capital Lease Obligation
—
0.00
-100.00%
65.03
-18.29%
79.59
Tradeand Other Payables Non Current
—
—
—
—
Non Current Deferred Liabilities
0.26
-99.78%
114.71
-27.19%
157.56
-15.17%
185.72
Non Current Deferred Revenue
0.26
-99.78%
114.71
-27.19%
157.56
-15.17%
185.72
Other Non Current Liabilities
85.62
+11.64%
76.70
+6.47%
72.03
-0.90%
72.69
Stockholders Equity
-30.04
+86.69%
-225.60
-10.50%
-204.17
-851.96%
-21.45
Common Stock Equity
-30.04
+86.69%
-225.60
-10.50%
-204.17
-851.96%
-21.45
Capital Stock
1.01
+0.30%
1.01
+2.13%
0.99
+4.88%
0.94
Common Stock
1.01
+0.30%
1.01
+2.13%
0.99
+4.88%
0.94
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
4.05
+0.25%
4.04
+2.17%
3.95
+4.89%
3.77
Ordinary Shares Number
4.05
+0.25%
4.04
+2.17%
3.95
+4.89%
3.77
Additional Paid In Capital
1,677.18
+0.51%
1,668.62
+1.52%
1,643.64
+6.66%
1,541.02
Retained Earnings
-1,706.05
+9.71%
-1,889.50
-2.58%
-1,841.92
-18.25%
-1,557.69
Gains Losses Not Affecting Retained Earnings
-2.18
+61.93%
-5.73
+16.63%
-6.88
-20.19%
-5.72
Minority Interest
34.51
-17.76%
41.97
+0.00%
41.97
+110.18%
19.97
Other Equity Adjustments
-2.18
+61.93%
-5.73
+16.63%
-6.88
-20.19%
-5.72
Total Equity Gross Minority Interest
4.47
+102.44%
-183.63
-13.22%
-162.20
-10859.39%
-1.48
Total Capitalization
-30.04
+80.30%
-152.51
-15.34%
-132.23
-516.55%
-21.45
Working Capital
69.83
+10.49%
63.20
-44.51%
113.89
-48.06%
219.26
Invested Capital
-30.04
+80.30%
-152.51
-15.34%
-132.23
-516.55%
-21.45
Total Debt
—
73.09
-51.15%
149.61
+66.45%
89.89
Net Debt
—
22.61
—
—
Capital Lease Obligations
—
0.00
-100.00%
77.68
-13.58%
89.89
Net Tangible Assets
-30.04
+86.69%
-225.60
-10.50%
-204.17
-851.96%
-21.45
Tangible Book Value
-30.04
+86.69%
-225.60
-10.50%
-204.17
-851.96%
-21.45
Non Current Accrued Expenses
—
—
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-4.77
+96.54%
-138.00
+56.19%
-315.02
-115.87%
-145.93
Cash Flow From Continuing Operating Activities
-4.77
+96.54%
-138.00
+56.19%
-315.02
-115.87%
-145.93
Net Income From Continuing Operations
183.45
+485.57%
-47.58
+83.26%
-284.23
+3.21%
-293.65
Depreciation Amortization Depletion
0.75
-72.21%
2.69
-72.89%
9.93
-6.36%
10.60
Depreciation
0.75
-72.21%
2.69
-72.89%
9.93
-6.36%
10.60
Depreciation And Amortization
0.75
-72.21%
2.69
-72.89%
9.93
-6.36%
10.60
Other Non Cash Items
—
—
32.37
+3024.52%
1.04
Stock Based Compensation
6.58
-73.92%
25.21
-50.33%
50.77
-22.61%
65.60
Asset Impairment Charge
2.06
0.00
-100.00%
1.00
0.00
Operating Gains Losses
-48.45
-3317.14%
-1.42
+39.99%
-2.36
-50.61%
-1.57
Gain Loss On Investment Securities
—
—
0.27
+5320.00%
0.01
Unrealized Gain Loss On Investment Securities
—
—
0.00
0.00
Gain Loss On Sale Of PPE
0.00
-100.00%
2.55
+63675.00%
0.00
+500.00%
-0.00
Change In Working Capital
-153.03
-30.29%
-117.46
+1.86%
-119.69
-269.94%
70.43
Change In Receivables
-2.54
+62.25%
-6.74
-296.24%
3.43
+348.76%
0.77
Changes In Account Receivables
-2.54
+62.25%
-6.74
-296.24%
3.43
+348.76%
0.77
Change In Inventory
5.36
-75.94%
22.28
+1414.69%
-1.70
+84.59%
-11.00
Change In Prepaid Assets
54.10
+447.92%
-15.55
+44.79%
-28.16
-672.93%
4.92
Change In Payables And Accrued Expense
-73.16
+5.00%
-77.01
-17.92%
-65.30
-167.67%
96.50
Change In Accrued Expense
-45.50
+50.28%
-91.52
-83.81%
-49.79
-154.96%
90.59
Change In Payable
-27.65
-290.56%
14.51
+193.54%
-15.51
-362.55%
5.91
Change In Account Payable
-27.65
-290.56%
14.51
+193.54%
-15.51
-362.55%
5.91
Change In Other Working Capital
-136.43
-382.13%
-28.30
-0.47%
-28.17
-581.99%
-4.13
Change In Other Current Assets
-0.09
-100.14%
67.32
+462.84%
11.96
+7.06%
11.17
Change In Other Current Liabilities
-0.28
+99.65%
-79.47
-576.27%
-11.75
+57.72%
-27.79
Investing Cash Flow
35.42
-71.89%
125.99
-18.00%
153.66
+72.42%
89.12
Cash Flow From Continuing Investing Activities
35.42
-71.89%
125.99
-18.00%
153.66
+72.42%
89.12
Net PPE Purchase And Sale
-0.04
-104.87%
0.78
+130.96%
-2.52
+32.56%
-3.73
Purchase Of PPE
-0.04
+85.71%
-0.27
+89.44%
-2.52
+32.67%
-3.74
Sale Of PPE
0.00
-100.00%
1.05
0.00
-100.00%
0.01
Capital Expenditure
-0.04
+85.71%
-0.27
+89.44%
-2.52
+93.50%
-38.74
Net Investment Purchase And Sale
-61.16
-148.84%
125.21
-19.49%
155.52
+21.64%
127.85
Purchase Of Investment
-61.16
-608.83%
-8.63
+96.57%
-251.83
-53.53%
-164.02
Sale Of Investment
0.00
-100.00%
133.84
-67.14%
407.35
+39.56%
291.87
Net Business Purchase And Sale
96.61
0.00
-100.00%
0.66
0.00
Purchase Of Business
—
—
—
0.00
Gain Loss On Sale Of Business
-52.55
0.00
—
—
Net Intangibles Purchase And Sale
—
—
0.00
+100.00%
-35.00
Purchase Of Intangibles
—
—
0.00
+100.00%
-35.00
Financing Cash Flow
-86.03
-33636.47%
-0.26
-100.21%
122.75
+162.42%
46.78
Cash Flow From Continuing Financing Activities
-86.03
-33636.47%
-0.26
-100.21%
122.75
+162.42%
46.78
Net Issuance Payments Of Debt
-75.01
-187425.00%
-0.04
-100.05%
73.59
+13779.18%
-0.54
Issuance Of Debt
—
0.00
-100.00%
74.08
0.00
Repayment Of Debt
-75.01
-187425.00%
-0.04
+91.74%
-0.48
+10.04%
-0.54
Long Term Debt Issuance
—
0.00
-100.00%
74.08
0.00
Long Term Debt Payments
-75.01
-187425.00%
-0.04
+91.74%
-0.48
+10.04%
-0.54
Net Long Term Debt Issuance
-75.01
-187425.00%
-0.04
-100.05%
73.59
+13779.18%
-0.54
Net Common Stock Issuance
—
0.00
-100.00%
48.41
0.00
Proceeds From Stock Option Exercised
0.00
-100.00%
0.14
-96.27%
3.73
-10.83%
4.18
Net Other Financing Charges
-11.02
-3012.43%
-0.35
+88.13%
-2.98
-106.92%
43.13
Changes In Cash
-55.38
-351.70%
-12.26
+68.25%
-38.62
-284.57%
-10.04
Effect Of Exchange Rate Changes
1.08
+43.41%
0.75
+122.11%
-3.40
+38.03%
-5.48
Beginning Cash Position
102.18
-10.12%
113.69
-26.98%
155.70
-9.07%
171.22
End Cash Position
47.87
-53.15%
102.18
-10.12%
113.69
-26.98%
155.70
Free Cash Flow
-4.81
+96.52%
-138.26
+56.46%
-317.54
-71.95%
-184.67
Interest Paid Supplemental Data
7.83
-51.69%
16.21
+153.91%
6.38
+6037.50%
0.10
Amortization Of Securities
-0.07
+95.71%
-1.68
+66.80%
-5.06
-412.60%
1.62
Change In Interest Payable
8.00
+252.09%
2.27
+20745.45%
-0.01
-133.33%
0.03
Common Stock Issuance
—
0.00
-100.00%
48.41
0.00
Dividend Received CFO
3.95
+77.00%
2.23
-1.11%
2.25
0.00
Earnings Losses From Equity Investments
-2.48
+37.39%
-3.97
-50.45%
-2.64
-67.71%
-1.57
Issuance Of Capital Stock
—
0.00
-100.00%
48.41
0.00
Sale Of Business
96.61
0.00
-100.00%
0.66
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category